Cassava Sciences Inc (SAVA)

2.59 +0.25 (+10.68%) USD  |  NASDAQ  |  Dec 26, 16:00
2.63 +0.04 (+1.54%) After-Hours: 05:13
More

Cassava Sciences EPS Estimates for Current Quarter

EPS Estimates for Current Quarter Chart

View EPS Estimates for Current Quarter for SAVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Earnings Per Share Estimates Definition

View Earnings Per Share Estimates Definition
Start Trial

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Current Quarter Range, Past 5 Years

View EPS Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Current Quarter Benchmarks

View EPS Estimates for Current Quarter Benchmarks
Start Trial
Bristol-Myers Squibb Co Upgrade
BridgeBio Pharma Inc Upgrade
Seelos Therapeutics Inc Upgrade
Alnylam Pharmaceuticals Inc Upgrade
EyePoint Pharmaceuticals Inc Upgrade

EPS Estimates for Current Quarter Related Metrics

EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade